Document is current
Any future updates will be listed below
-
Authors
Craven, Elliott J.
Latham, Jonathan https://orcid.org/0000-0002-5906-9024
Shepherd, Sarah A. https://orcid.org/0000-0002-7321-1234
Khan, Imtiaz https://orcid.org/0000-0001-7359-1727
Diaz-Rodriguez, Alba
Greaney, Michael F. https://orcid.org/0000-0001-9633-1135
Micklefield, Jason https://orcid.org/0000-0001-8951-4873
-
Funding
Funding for this research was provided by:
RCUK | Biotechnology and Biological Sciences Research Council (BB/R01034X/1)
RCUK | Biotechnology and Biological Sciences Research Council (BB/R01034X/1)
RCUK | Biotechnology and Biological Sciences Research Council (BB/R01034X/1)
RCUK | Biotechnology and Biological Sciences Research Council (BB/R01034X/1)
GlaxoSmithKline
- License Information
-
More Information
Article History
Received: 12 August 2020
Accepted: 16 March 2021
First Online: 29 April 2021
Competing interests
: The authors declare no competing interests.
